Update on tuberculosis: TB in the early 21st century

  • D.W. C
  • M. B
  • G. C
  • 1

    Readers

    Mendeley users who have this article in their library.
  • N/A

    Citations

    Citations of this article.

Author-supplied keywords

  • *tuberculosis/di [Diagnosis]
  • *tuberculosis/dr [Drug Resistance]
  • *tuberculosis/dt [Drug Therapy]
  • *tuberculosis/ep [Epidemiology]
  • *tuberculosis/pc [Prevention]
  • 25 hydroxyvitamin D/ec [Endogenous Compound]
  • 6,7 dihydro 2 nitro 6 (4 trifluoromethoxybenzyloxy
  • BCG vaccine/dt [Drug Therapy]
  • Europe
  • Human immunodeficiency virus infection/dt [Drug Th
  • Human immunodeficiency virus proteinase inhibitor/
  • Mycobacterium tuberculosis
  • antibiotic sensitivity
  • article
  • bacterial transmission
  • bacterium culture
  • bedaquiline/ae [Adverse Drug Reaction]
  • bedaquiline/ct [Clinical Trial]
  • bedaquiline/dt [Drug Therapy]
  • biomass
  • cigarette smoking
  • ciprofloxacin/dt [Drug Therapy]
  • delamanid/ct [Clinical Trial]
  • delamanid/dt [Drug Therapy]
  • dexamethasone/dt [Drug Therapy]
  • drug megadose
  • drug substitution
  • drug withdrawal
  • efavirenz/dt [Drug Therapy]
  • endobronchial ultrasonography
  • enzyme linked immunosorbent assay
  • enzyme linked immunospot assay
  • ethambutol/dt [Drug Therapy]
  • extensively drug resistant tuberculosis
  • gamma interferon/ec [Endogenous Compound]
  • glucocorticoid/dt [Drug Therapy]
  • highly active antiretroviral therapy
  • human
  • imipenem/ct [Clinical Trial]
  • imipenem/dt [Drug Therapy]
  • immune reconstitution inflammatory syndrome
  • incidence
  • interferon gamma release assay
  • interleukin 4/ec [Endogenous Compound]
  • isoniazid/cb [Drug Combination]
  • isoniazid/do [Drug Dose]
  • isoniazid/dt [Drug Therapy]
  • kanamycin/dt [Drug Therapy]
  • latent tuberculosis/di [Diagnosis]
  • latent tuberculosis/si [Side Effect]
  • linezolid/ct [Clinical Trial]
  • linezolid/dt [Drug Therapy]
  • lipoarabinomannan
  • lung tuberculosis/di [Diagnosis]
  • migration
  • mixed infection
  • moxifloxacin/ct [Clinical Trial]
  • moxifloxacin/dt [Drug Therapy]
  • multidrug resistant tuberculosis/dt [Drug Therapy]
  • n (2 adamantyl) n' geranylethylenediamine/ct [Clin
  • n (2 adamantyl) n' geranylethylenediamine/dt [Drug
  • nevirapine/dt [Drug Therapy]
  • nonnucleoside reverse transcriptase inhibitor/dt [
  • nucleic acid amplification
  • placebo
  • pnu 100480
  • pyrazinamide/dt [Drug Therapy]
  • rifabutin/dt [Drug Therapy]
  • rifampicin/cb [Drug Combination]
  • rifampicin/dt [Drug Therapy]
  • rifapentine/ct [Clinical Trial]
  • rifapentine/dt [Drug Therapy]
  • sputum smear
  • transbronchial aspiration
  • tuberculosis control
  • tuberculous lymphadenitis/dt [Drug Therapy]
  • tuberculous lymphadenitis/su [Surgery]
  • tuberculous meningitis/dt [Drug Therapy]
  • tumor necrosis factor alpha inhibitor/ae [Adverse
  • unclassified drug
  • unindexed drug
  • unspecified side effect/si [Side Effect]
  • vitamin D deficiency/dt [Drug Therapy]
  • vitamin D/ct [Clinical Trial]
  • vitamin D/dt [Drug Therapy]

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Connell D.W.

  • Berry M.

  • Cooke G.

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free